Preclinical Toxicity Assessment of Ti-Based MXene Nanomaterials for Advanced Theranostic Applications


Journal article


Barkha Singh, Rohan Bahadur, Deepika Rai, Rohit Srivastava
Advanced Therapeutics, vol. 7, 2024, p. 2300268


Cite

Cite

APA   Click to copy
Singh, B., Bahadur, R., Rai, D., & Srivastava, R. (2024). Preclinical Toxicity Assessment of Ti-Based MXene Nanomaterials for Advanced Theranostic Applications. Advanced Therapeutics, 7, 2300268. https://doi.org/10.1002/adtp.202300268


Chicago/Turabian   Click to copy
Singh, Barkha, Rohan Bahadur, Deepika Rai, and Rohit Srivastava. “Preclinical Toxicity Assessment of Ti-Based MXene Nanomaterials for Advanced Theranostic Applications.” Advanced Therapeutics 7 (2024): 2300268.


MLA   Click to copy
Singh, Barkha, et al. “Preclinical Toxicity Assessment of Ti-Based MXene Nanomaterials for Advanced Theranostic Applications.” Advanced Therapeutics, vol. 7, 2024, p. 2300268, doi:10.1002/adtp.202300268.


BibTeX   Click to copy

@article{singh2024a,
  title = {Preclinical Toxicity Assessment of Ti-Based MXene Nanomaterials for Advanced Theranostic Applications},
  year = {2024},
  journal = {Advanced Therapeutics},
  pages = {2300268},
  volume = {7},
  doi = {10.1002/adtp.202300268},
  author = {Singh, Barkha and Bahadur, Rohan and Rai, Deepika and Srivastava, Rohit}
}


Share



Follow this website


You need to create an Owlstown account to follow this website.


Sign up

Already an Owlstown member?

Log in